Open AccessPhase III Belinda Study for Aggressive B-Cell Lymphoma
Author(s) -
Dibash Kumar Das
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000852784.13307.4d
Subject(s) - medicine , lymphoma , aggressive lymphoma , oncology , b cell lymphoma , hematopoietic stem cell transplantation , b cell , rituximab , chemotherapy , transplantation , immunology , antibody